2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of …
E Arbelo, A Protonotarios, JR Gimeno… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
Heart disease and stroke statistics—2022 update: a report from the American Heart Association
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …
Authors/Task Force Members:… - European journal of …, 2022 - Wiley Online Library
Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …
The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …
Heart disease and stroke statistics—2019 update: a report from the American Heart Association
EJ Benjamin, P Muntner, A Alonso, MS Bittencourt… - Circulation, 2019 - Am Heart Assoc
Summary Each year, the American Heart Association (AHA), in conjunction with the National
Institutes of Health and other government agencies, brings together in a single document the …
Institutes of Health and other government agencies, brings together in a single document the …
Heart disease and stroke statistics—2020 update: a report from the American Heart Association
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports on the most up-to-date statistics related to heart disease, stroke …
Health, annually reports on the most up-to-date statistics related to heart disease, stroke …
Heart disease and stroke statistics—2021 update: a report from the American Heart Association
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Evaluation for Heart Transplantation and LVAD Implantation: JACC Council Perspectives
M Guglin, MJ Zucker, BA Borlaug, E Breen… - Journal of the American …, 2020 - jacc.org
Timely referrals for transplantation and left ventricular assist device implantation play a key
role in favorable outcomes in patients with advanced heart failure. Nonetheless, evaluation …
role in favorable outcomes in patients with advanced heart failure. Nonetheless, evaluation …
Prognostic value of peak oxygen uptake in patients supported with left ventricular assist devices (PRO-VAD)
KK Mirza, MK Szymanski, T Schmidt, N de Jonge… - Heart Failure, 2021 - jacc.org
Objectives The purpose of this study was to examine whether peak oxygen uptake (pVo2)
and other cardiopulmonary exercise test (CPET)-derived variables could predict …
and other cardiopulmonary exercise test (CPET)-derived variables could predict …
Obesity, organ failure, and transplantation: A review of the role of metabolic and bariatric surgery in transplant candidates and recipients
Obesity is a risk factor for kidney, liver, heart, and pulmonary diseases, as well as failure.
Solid organ transplantation remains the definitive treatment for the end-stage presentation of …
Solid organ transplantation remains the definitive treatment for the end-stage presentation of …